Mxi1 mutations in human neurofibrosarcomas

Mxil is thought to negatively regulate Myc function and may therefore be a potential tumor suppressor gene. Little effort has Set been made to find alterations involving this gene in human solid tumors. We screened 31 human gastric cancers, 7 esophageal cancers, 85 bone and soft tissue tumors of various types, including 4 neurofibrosarcomas, We also examined 29 human tumor cell lines consisting of 12 esophageal cancers, 7 glioma/glioblastomas and 10 others for Mxil mutations in exons 1, 2, 4 (HLH domain), 5 and 6, Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and subsequent sequencing revealed three distinct polymorphisms in the intron-exon boundary upstream from exon 6, We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gin) and GAA to GCA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3), Ln case 3, loss of heterozygosity was also demonstrated by informative (TTC),I(TTC)2 polymorphism. Our data demonstrate that mutations occur in the Mxil gene in neurofibrosarcoma, Missense mutations in the functional domain of Mxil in these cases may be involved in the pathogenesis of neurofibrosarcoma.